Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Quentin30


T.ONC

RE:RE:RE:RE:RE:RE:RE:Keytruda+Chemo neoadjuvant in early ER+/HER2- breast cancer

Dammit, you made me laugh out loud again Azzak..!! no-one knows what's...

October 20, 2023

T.ONC

RE:RE:RE:RE:RE:Keytruda+Chemo neoadjuvant in early ER+/HER2- breast cancer

perhaps Roche will wait until the patent expires in a couple of years... and...

October 20, 2023

T.ONC

RE:RE:RE:Keytruda+Chemo neoadjuvant in early ER+/HER2- breast cancer

ONCY are pursuing a standard approval process... show me where MATT has...

October 20, 2023

T.ONC

valuation...

Holy moly... how low will we go... if the idea in trading is to buy the...

October 18, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA's Head of CBER wants faster approvals with SE/biomarkers

perhaps when the investment community agrees with you and an offer is made...

October 17, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:FDA's Head of CBER wants faster approvals with SE/biomarkers

showig safety and efficacy, but data was not collected to show TCR clonality...

October 17, 2023

T.ONC

RE:RE:RE:RE:RE:RE:FDA's Head of CBER wants faster approvals with SE/biomarkers

you actually made me laugh out loud today... thank you...  NO, not...

October 17, 2023

T.ONC

RE:RE:RE:RE:FDA's Head of CBER wants faster approvals with SE/biomarkers

Has ONCY proven this to the satisfaction of the FDA yet ? A potential...

October 17, 2023

T.ONC

Huzzah two poster presentations...

We're really rocking here now... Two poster presentations to come at ESMO...

October 16, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Example of details involved in acquisition talks: like ONCY

Keep hoping Azzak... only way to make money on this stock is to trade it...

October 12, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Example of details involved in acquisition talks: like ONCY

great.. buy as much as you like... and when it drops again tomorrow and into...

October 12, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Example of details involved in acquisition talks: like ONCY

actually Azzak, I wouldn't say the science is 'unequivocal' yet.....

October 12, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Stuff is happening

wow... stock price is cratering again... I bet the recent 'health care...

October 6, 2023

T.ONC

RE:RE:RE:RE:RE:RE:PPS

Grammatically speaking, it should be 'your' not 'you're'....

September 29, 2023

T.ONC

RE:Adlai Nortye Ltd prices offering at US$23 per share

excellent, now there is another way to lose money on ONCY...!!

September 29, 2023

T.ONC

RE:RE:RE:RE:PPS

I see ONCY is down again... hmmm..  26 years of buying oportunities...

September 29, 2023

T.ONC

RE:RE:PPS

Not buying when you pumpers are saying its worth 10 billion and going to the...

September 29, 2023

T.ONC

PPS

hmmm, seems we're running out of inflection points for stock price...

September 28, 2023

T.ONC

RE:RE:New Company Website URL

It looks more like they are targetting partners more than patients (just my...

September 28, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:Roche & Tecentriq.

You're absolutely right about me talking garbage... since I did state...

September 27, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next